Beyond the scalpel: Targeting hedgehog in skin cancer prevention

Cancer Prevention Research

Volumn 3, Issue 1, 2010, Pages 1-3

  Rudin, Charles M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GDC 0449; N (3 METHOXYBENZYL) 3,3 DIMETHYL N [1 (3,4 METHYLENEDIOXYBENZYL) 2 (1 PIPERAZINYLCARBONYL) 4 PYRROLIDINYL]BUTYRAMIDE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BASAL CELL CARCINOMA; CANCER GENETICS; CANCER PREVENTION; CANCER SURGERY; CARCINOGENESIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; NONHUMAN; PRIORITY JOURNAL; SCALPEL; SHORT SURVEY; SKIN CANCER; TREATMENT RESPONSE; ANIMAL; GENETICS; METABOLISM; MOUSE; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; HEDGEHOG PROTEINS; HUMANS; MICE; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 77649219333     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0245     Document Type: Short Survey

References (17)

1. American Cancer Society. Cancer facts and figures 2009. 2009, Available from: http://www.cancer.org.
2. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005;353:2262-9.
3. Gorlin RJ. Nevoid basal cell carcinoma (Gorlin) syndrome. Genet Med 2004;6:530-9.
4. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008;8:743-54.
5. Jiang J, Hui CC. Hedgehog signaling in development and cancer. Dev Cell 2008;15:801-12.
6. Hahn H, Wicking C, Zaphiropoulous PG, et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996;85:841-51.
7. Johnson RL, Rothman AL, Xie J, et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 1996; 272:1668-71.
8. Tang JY, AxzterbaumM, Athar M, et al. Basal cell carcinoma chemoprevention with non-steroidal anti-inflammatory drugs in genetically-predisposedPTCH1+/-humans andmice. Cancer Prev Res 2010;3:25-34.
9. Papadimitrakopoulou VA, Lee JJ, William WN, Jr., et al. Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without β-carotene in oral premalignancy. J Clin Oncol 2009;27: 599-604.
10. Nusslein-Volhard C, Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980;287:795-801.
11. van den Heuvel M, Ingham PW. Smoothened encodes a receptorlike serpentine protein required for hedgehog signalling. Nature 1996;382:547-51.
12. Vorechovsky I, Tingby O, Hartman M, et al. Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours. Oncogene 1997;15:361-6.
13. Taipale J, Chen JK, Cooper MK, et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000;406:1005-9.
14. Rudin CM, Hann CL, Laterra J, et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009; 361:1173-8.
15. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009; 361:1164-72.
16. Yauch RL, Dijkgraaf GJ, Alicke B, et al. Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma. Science 2009;326:572-4.
17. Bailey JM, Singh PK, Hollingsworth MA. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 2007;102:829-39.